Reem Hal/LinkedIn
Dec 25, 2025, 23:39
Reem Hal Shares New Clinical Capsule: Thrombosis in Cancer Patients
Reem Hal, Senior Pediatric Oncology Clinical Pharmacist at Borg El Arab Main University Hospital, shared a post on LinkedIn:
“Clinical Capsule | Oncology Rounds
Capsule #5 – Thrombosis in Cancer Patients
‘The cancer didn’t cause the ICU admission — the missed prophylaxis did.’
A patient with multiple myeloma on
lenalidomide + dexamethasone
missed thromboprophylaxis →
acute myocardial infarction. ICU admission.
Clinical Pearl
IMiD-based regimens dramatically increase thrombotic risk.
Standard practice
- Low risk → Aspirin
- High risk → LMWH or DOAC
Missed prophylaxis may lead to
- MI or stroke
- Treatment interruption
Take-home message
In multiple myeloma, thromboprophylaxis is not optional — it is life-saving.”

Follow the latest in Hemostasis Today.
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer
-
Nov 8, 2026, 05:24Recognising Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding – RPTH Journal
-
Nov 8, 2026, 05:11WFH CCS 2027 Abstract Submission Now Open – World Federation of Hemophilia